Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/4992
Title: | Organocatalyzed umpolung addition for synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agents |
Authors: | Joshi, Mayank Choudhury, Angshuman Roy |
Keywords: | Organocatalyzed umpolung synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agents |
Issue Date: | 2022 |
Publisher: | Elsevier |
Citation: | Bioorganic and Medicinal Chemistry, 67(1), 116835. |
Abstract: | A strategy of “Nature-to-new” with iterative scaffold-hopping was considered for investigation of privileged ring/functional motif-elaborated analogs of natural aurones. An organocatalyzed umpolung chemistry based method was established for molecular-diversity feasible synthesis of title class of chemotypes i.e. (Z)-2-Arylideneimidazo[1,2–a]pyridinones and (Z)-2-Arylidenebenzo[d]imidazo[2,1–b]thiazol-3-ones. Various biophysical experiments indicated their important biological properties. The analogs showed characteristic anticancer activities with efficiency more than an anticancer drug. The compounds induced apoptosis with arrest in the S phase of the cell cycle regulation. The compounds’ significant effect in up/down-regulation of various apoptotic proteins, an apoptosis cascade, and the inhibition of topoisomerases-mediated DNA relaxation process was identified. The analysis of the structure-activity relationship, interference with biological events and the drug-likeness physicochemical properties of the compounds in the acceptable window indicated distinctive medicinal molecule-to-properties of the investigated chemotypes. |
Description: | Only IISER Mohali authors are available in the record. |
URI: | https://doi.org/10.1016/j.bmc.2022.116835 http://hdl.handle.net/123456789/4992 |
Appears in Collections: | Research Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Need To Add…Full Text_PDF. | 15.36 kB | Unknown | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.